1.
M V, K N, A A, Siddalingegowda SM. Targeting Metabolic Pathways for Neurodegeneration: The Emerging Role of Anti-Diabetic and Lipid-Lowering Agents. Int. J. of Allied Med. Sci. and Clin. Res. [Internet]. 2025 Nov. 7 [cited 2026 Mar. 12];13(4):633-42. Available from: https://ijamscr.com/ijamscr/article/view/1681